MR 7700 Multinuclear Application Clinical Study
Starting soon · Not applicable
Conditions studied: Hepatocellular Carcinoma, MRI
In brief
The purpose of this clinical study is to perform phosphorus nucleus (31P) and sodium nucleus (23Na) imaging of the liver in patients with primary hepatocellular carcinoma (HCC) and healthy volunteers using the MR 7700 Magnetic Resonance Equipment, in order to explore the manifestations of multinuclear imaging in HCC patients and healthy volunteers.
Key facts
- Study ID
- NCT07368049
- Run by
- Philips Clinical & Medical Affairs Global
- People needed
- 100
- Starts
- 2026-01-05
- Expected to finish
- 2026-08-31
- Last updated by the study team
- 2026-01-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 1. HCC patient group
- Age ≥ 18 years;
- With clear consciousness, ability to cooperate, and autonomous behavior;
- Voluntary agreement to participate in this clinical trial and signing of the subject's informed consent form;
- Patients diagnosed with primary hepatocellular carcinoma by imaging or clinical diagnosis, and who have not received tumor treatment.
- 2. Healthy control group
- Age ≥ 18 years;
- With clear consciousness, ability to cooperate, and autonomous behavior;
- Voluntary agreement to participate in this clinical trial and signing of the subject's informed consent form;
- No previous history of liver disease.
You may not qualify if…
- HCC patient group and healthy control group
- Patients with claustrophobia.
- Subject's body temperature > 39.5°C on the day of scanning.
- Females who plan to be pregnant within 6 months, and pregnant and lactating females.
- Patients with other implants, prostheses, foreign bodies, patches, etc. that are not suitable for MRI examination; patients with electronic implants, such as pacemakers, stimulators, insulin pumps, cochlear implants, etc.
- Critically ill subjects with various resuscitation devices or those with any emergency medical condition requiring first aid.
- Subjects with poor compliance are considered to be excluded by the investigators.
- Subjects who are not considered suitable for this trial by the investigators.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.